SynthesisClinical interventions in aging2025
The Relation of Osteoporotic Vertebral Fractures and Sarcopenic Characteristics on the Occurrence of Complications: A Systematic Review.
Synthesis in Clinical interventions in aging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Study Design: Systematic review. Purpose: As the number of elderly increases, age-related changes of body composition like osteoporosis and sarcopenic muscle changes contribute to higher morbidity, less quality of life and higher health care costs. Data on the effect of muscle atrophy on osteoporotic vertebral fractures is limited. We systematically reviewed the current literature for the influence of preexisting degenerative muscle changes in patients with OVF on the occurrence of complication during and after treatment. Methods: A systematic literature review adherent to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines was performed using the Web of Science and Medline databases. We considered English and German articles from January 1990 to December 2022. Inclusion criteria covered patients with OVF and muscle degeneration with complications during and after treatment. Included trials were cohort studies and case series. Results: Eight Studies were included in this systematic review. One studied the role of degenerated paravertebral muscle during conservative treatment. One article analysed the influence of sarcopenia after dorsal instrumentation in patients with OVF, another the effects of muscle degeneration after dorsal instrumentation or kyphoplasty. The other studies evaluated complications after percutaneous vertebroplasty or kyphoplasty. Seven studies described an increased risk for subsequent fracture following OVF treatment in case of muscle degeneration, despite differing methods and cut-offs for muscle degeneration. Conclusion: Subsequent fractures were the most frequently analysed complication, others were scarcely analysed. Most studies found a correlation of paravertebral muscle degeneration and the occurrence of secondary OVFs. However, very different methods and cut-offs for sarcopenia assessment were used and it remains unclear what defines muscle changes that lead to an increased risk for complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.